|
|
Research
Eisai is a human health care (hhc) company seeking innovative solutions in disease prevention, cure, and care of the health and well-being of people worldwide.
The ability to conduct basic and clinical research in the United States strengthens Eisai's resources in the pharmaceutical market and helps the company meet highly competitive research and development goals, enhancing Eisai's proven ability to discover new medicines.
Research facilities in the United States include Eisai Research Institute in Andover, Massachusetts; Eisai Medical Research Inc. in Ridgefield Park, New Jersey; and Eisai Inc.'s Research Triangle Park facility in North Carolina.
Approximately 13 percent of Eisai's worldwide revenue is spent on research and development, with emphasis on four therapeutic areas - neurology, gastrointestinal disorders, cancer and acute care. All of our current products as well as our drugs in clinical trials focus on our key therapeutic areas.
 Printer Friendly Version
|
|
